Uniogen is specialized in cancer diagnostics, molecular and immunoassay diagnostics of infectious diseases, and laboratory instrumentation. We are targeting the diagnostics market with new, innovative solutions under development for early cancer detection in central laboratories, and in various laboratory and decentralized healthcare settings.
| Website | http://www.uniogen.com |
| Employees | 53 (34 on RocketReach) |
| Founded | 2022 |
| Address | Tykistökatu 4, Turku, Southwest Finland 20520, FI |
| Industry | Biotechnology Research |
| Keywords | Early Cancer Detection, Cancer Diagnostics, Cancer Testing, Biomedical Diagnostics, Molecular Diagnostics, Molecular Assays, Clinical Diagnostics, In-Vitro Diagnostics, Healthcare Diagnostics, Medical Diagnostics, Diagnostic Testing, Infectious Disease Diagnostics, Infectious Disease Testing, Disease Diagnostics, Diagnostic Instruments, Laboratory Instrumentation, Medical Devices, Lab Equipment |
| Competitors | NervGen Pharma Corp., Neurotrope Inc., Neuralstem, Inc., Abeona Therapeutics, Aphria, Sorrento Therapeutics, Inc., Axovant Sciences Ltd, VistaGen Therapeutics, Inc., Intrasense, Neuraltus Pharmaceuticals +38 more (view full list) |
Looking for a particular Uniogen employee's phone or email?
Miro Marttila is the CFO of Uniogen.
34 people are employed at Uniogen.
Uniogen is based in Turku, Southwest Finland.